Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
Tom L BlundellDavid Burke

Abstract

Impressive progress in genome sequencing, protein expression and high-throughput crystallography and NMR has radically transformed the opportunities to use protein three-dimensional structures to accelerate drug discovery, but the quantity and complexity of the data have ensured a central place for informatics. Structural biology and bioinformatics have assisted in lead optimization and target identification where they have well established roles; they can now contribute to lead discovery, exploiting high-throughput methods of structure determination that provide powerful approaches to screening of fragment binding.

References

Jun 1, 1976·British Journal of Pharmacology·C R BeddellR Wootton
Feb 1, 1992·Protein Science : a Publication of the Protein Society·J OveringtonT L Blundell
Sep 5, 1992·Journal of Molecular Biology·C A McPhalenC Chothia
Jul 2, 1992·Nature·D T JonesJ M Thornton
Mar 15, 1988·European Journal of Biochemistry·T BlundellM Sutcliffe
Sep 24, 1987·Nature·L H Pearl, W R Taylor
Jun 20, 1987·Journal of Molecular Biology·M J ZvelebilM J Sternberg
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·S R PetersonD J Chen
Jan 1, 1994·Annual Review of Biophysics and Biomolecular Structure·P J Whittle, T L Blundell
Dec 5, 1993·Journal of Molecular Biology·A Sali, T L Blundell
Feb 1, 1996·Biochemical Society Transactions·C Gómez-MorenoG Tollin
Sep 1, 1996·Proceedings of the Society for Experimental Biology and Medicine·R Ray
Nov 7, 1996·Nature·T L Blundell
Nov 29, 1996·Science·S B ShukerS W Fesik
Nov 1, 1996·Journal of Chemical Information and Computer Sciences·Z LuoL Lai
Dec 1, 1996·Protein Science : a Publication of the Protein Society·R A LaskowskiJ M Thornton
Jan 1, 1996·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·D W ChanS P Lees-Miller
Apr 1, 1997·Nature Biotechnology·J C Hogan
Nov 26, 1998·Proteins·M A Rodionov, T L Blundell
Dec 10, 1998·Nucleic Acids Research·K HofmannA Bairoch
Mar 5, 1999·Journal of Molecular Biology·A Kasuya, J M Thornton
Jan 7, 2000·Journal of Molecular Biology·E Lindahl, A Elofsson
Sep 21, 2000·Clinical Science·S F Campbell
Jan 11, 2001·Proteins·J A IrvingA M Lesk
May 10, 2001·Protein Science : a Publication of the Protein Society·C M Deane, T L Blundell
Jul 27, 2001·Current Opinion in Chemical Biology·R Abagyan, M Totrov
Sep 12, 2001·Journal of Structural Biology·J A Di GennaroJ S Fetrow
Nov 10, 2001·Nature Structural Biology·B L SibandaL Pellegrini

❮ Previous
Next ❯

Citations

Apr 15, 2009·Journal of Molecular Evolution·Stephen M Chong, J-P Jin
Oct 19, 2012·Cell Death & Disease·K-S ChanH-Y Li
Mar 10, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Keiran FlemingMichael J E Sternberg
Mar 10, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·David T JonesJanet M Thornton
Jun 23, 2010·Journal of Synchrotron Radiation·Zbigniew DauterAlexander Wlodawer
Apr 2, 2011·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·German ReyesImogen R Coe
Apr 5, 2012·Journal of Clinical Bioinformatics·Khader Shameer, Ramanathan Sowdhamini
Apr 21, 2010·PloS One·Niu Huang, Matthew P Jacobson
Jun 11, 2014·Acta Crystallographica. Section D, Biological Crystallography·Kevin PröpperIsabel Usón
Aug 8, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Francesco Musiani, Stefano Ciurli
Sep 2, 2015·Expert Review of Proteomics·Emily H BowlerRob M Ewing
Jun 1, 2012·Expert Opinion on Drug Discovery·Nagasuma Chandra
Feb 11, 2015·Progress in Biophysics and Molecular Biology·Harry JubbDavid B Ascher
Jun 6, 2013·Current Opinion in Pharmacology·Alicia P HiguerueloTom L Blundell
Apr 17, 2012·Trends in Pharmacological Sciences·Harry JubbTom L Blundell
May 9, 2009·Drug Discovery Today·Claudio N Cavasotto, Sharangdhar S Phatak
Apr 23, 2009·Biochimie·Guilhem FaureAlexandre G de Brevern
Apr 3, 2009·Trends in Biotechnology·Rob L M van Montfort, Paul Workman
Apr 7, 2009·Progress in Biophysics and Molecular Biology·Jörg Gsponer, M Madan Babu
Dec 19, 2007·Biochimie·Guilhem FaureAlexandre G de Brevern
Oct 9, 2009·Chemical Biology & Drug Design·Alícia P HiguerueloTom L Blundell
Feb 26, 2009·Proteins·Aurélie BornotAlexandre G de Brevern
May 10, 2007·Journal of Cellular and Molecular Medicine·K Lundstrom
Feb 3, 2011·Proteins·Aurélie BornotAlexandre G de Brevern
Oct 30, 2013·Journal of Cellular Biochemistry·Chih-Chien ChouChing-Shih Chen
Jun 15, 2010·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·David Pérez-MartínezTerence H Rabbitts
Jan 28, 2016·Protein Science : a Publication of the Protein Society·Hui Sun Lee, Wonpil Im
Mar 20, 2008·Expert Opinion on Therapeutic Targets·Yi-Ping Phoebe Chen, Feng Chen
Apr 7, 2016·Nature Reviews. Drug Discovery·Duncan E ScottJohn Skidmore
Jan 31, 2012·Chemistry & Biology·Sachin Surade, Tom L Blundell
Jan 13, 2015·Chemical Communications : Chem Comm·Laura Nevola, Ernest Giralt
Apr 15, 2017·Biochemical Society Transactions·Arun Prasad PanduranganTom L Blundell
Jun 9, 2018·Nature Reviews. Drug Discovery·Jean-Paul RenaudChristian Wiesmann
Dec 2, 2010·HFSP Journal·Richard Giegé, Claude Sauter
Jan 7, 2010·Protein Science : a Publication of the Protein Society·Avner SchlessingerAndrej Sali
Jan 25, 2013·Chembiochem : a European Journal of Chemical Biology·Duncan E ScottMarko Hyvönen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Reviews. Drug Discovery
Andrew L Hopkins, Colin R Groom
Drug Discovery Today
Miles CongreveTom L Blundell
© 2021 Meta ULC. All rights reserved